These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37173988)

  • 1. Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer.
    Matoska T; Banerjee A; Shreenivas A; Jurkowski L; Shukla ME; Gore EM; Linsky P; Gasparri M; George B; Johnstone C; Johnstone D; Puckett LL
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution.
    Yegya-Raman N; Aisner J; Kim S; Sayan M; Li D; Langenfeld J; Patel M; Malhotra J; Jabbour SK
    Adv Radiat Oncol; 2019; 4(3):541-550. PubMed ID: 31360811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer.
    de Vos-Geelen J; Hoebers FJP; Geurts SME; Hoeben A; de Greef BTA; Voncken FEM; Bogers JHA; Braam PM; Muijs CKT; de Jong MA; Kasperts N; Rozema T; Jeene PM; Blom GJ; van Dieren JM; Hulshof MCCM; van Laarhoven HWM; Grabsch HI; Lemmens VEPP; Tjan-Heijnen VCG; Nieuwenhuijzen GAP
    Acta Oncol; 2020 Aug; 59(8):895-903. PubMed ID: 32319845
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.
    Wang J; Suri JS; Allen PK; Liao Z; Komaki R; Ho L; Hofstetter WL; Lin SH
    Am J Clin Oncol; 2016 Jun; 39(3):228-35. PubMed ID: 24710122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
    Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
    J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies.
    Su S; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y; Wang X; Li T; Li J; Chen M; Lu Y; Bai Y; He Z; Lu B
    BMC Cancer; 2016 Nov; 16(1):908. PubMed ID: 27871270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery.
    Wright CM; Lee DY; Shimunov D; Carmona R; Barsky AR; Sun L; Cohen RB; Bauml JM; Brody RM; Basu D; Rassekh CH; Chalian AA; Newman JG; Rajasekaran K; Weinstein GS; Lukens JN; Lin A; Swisher-McClure S
    Oral Oncol; 2021 Oct; 121():105509. PubMed ID: 34474270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiation for elderly patients (≥ 65 years) with esophageal cancer: a retrospective single-center analysis.
    Linde P; Mallmann M; Adams A; Wegen S; Rosenbrock J; Trommer M; Marnitz S; Baues C; Celik E
    Radiat Oncol; 2022 Nov; 17(1):187. PubMed ID: 36397163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
    Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.
    Kim HJ; Suh YG; Lee YC; Lee SK; Shin SK; Cho BC; Lee CG
    Cancer Res Treat; 2017 Jul; 49(3):669-677. PubMed ID: 27737537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.
    Golden DW; Novak CJ; Minsky BD; Liauw SL
    Radiat Oncol; 2012 Sep; 7():156. PubMed ID: 22974515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Single-Arm Confirmatory Study of Definitive Chemoradiation Therapy Including Salvage Treatment for Clinical Stage II/III Esophageal Squamous Cell Carcinoma (JCOG0909 Study).
    Takeuchi H; Ito Y; Machida R; Kato K; Onozawa M; Minashi K; Yano T; Nakamura K; Tsushima T; Hara H; Okuno T; Hironaka S; Nozaki I; Ura T; Chin K; Kojima T; Seki S; Sakanaka K; Fukuda H; Kitagawa Y;
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):454-462. PubMed ID: 35932949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
    Rao YJ; Chin RI; Hui C; Mutch DG; Powell MA; Schwarz JK; Grigsby PW; Markovina S
    Gynecol Oncol; 2017 Sep; 146(3):572-579. PubMed ID: 28662775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option.
    Faehling M; Fallscheer S; Kramberg S; Sträter J; Eschmann S; Sätzler R; Heinzelmann F
    Eur J Cancer; 2021 Oct; 156():175-186. PubMed ID: 34461420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.
    Ning MS; Ahobila V; Jhingran A; Stecklein SR; Frumovitz M; Schmeler KM; Eifel PJ; Klopp AH
    Gynecol Oncol; 2018 Jan; 148(1):132-138. PubMed ID: 29089122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC.
    Gauvin C; Krishnan V; Kaci I; Tran-Thanh D; Bédard K; Albadine R; Leduc C; Gaboury L; Blais N; Tehfe M; Routy B; Florescu M
    Curr Oncol; 2021 Jan; 28(1):593-605. PubMed ID: 33498159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses.
    Shi Z; Zhu X; Ke S; Qiu H; Cai G; Zhangcai Y; Chen Y
    Radiother Oncol; 2021 Nov; 164():236-244. PubMed ID: 34627936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.
    He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M
    Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.